Abstract
This lecture aimed to create a bridge to span the conceptual and ideological gap between randomised controlled trials and systematic observational comparisons and to reduce unwanted and unproductive polarisation. The argument, simply put, is that since randomisation alone eliminates the selection effect of therapeutic decision making, anything short of randomisation to attribute cause to consequent outcome is a waste of time. If observational comparison does have any significant part in evaluating medical outcomes, there is a grave danger of "the best", to paraphrase Voltaire, becoming "the enemy of the good". The first section aims to emphasise the advantages of randomised controlled trials. Then the nature of an essential precondition--medical uncertainty--is discussed in terms of its extent and effect. Next, the role of patient choice in medical decision making is considered, both when outcomes can safely be attributed to treatment choice and when they cannot. There may be many important situations in which choice itself affects outcome and this could mean that random comparisons give biased estimates of true therapeutic effects. In the penultimate section, the implications of this possibility both for randomised controlled trials and for outcome research is pursued and lastly there are some simple recommendations for reliable outcome research.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Asher W. L., Harper H. W. Effect of human chorionic gonadotrophin on weight loss, hunger, and feeling of well-being. Am J Clin Nutr. 1973 Feb;26(2):211–218. doi: 10.1093/ajcn/26.2.211. [DOI] [PubMed] [Google Scholar]
- Barry M. J., Mulley A. G., Jr, Fowler F. J., Wennberg J. W. Watchful waiting vs immediate transurethral resection for symptomatic prostatism. The importance of patients' preferences. JAMA. 1988 May 27;259(20):3010–3017. [PubMed] [Google Scholar]
- Bracken M. B. Clinical trials and the acceptance of uncertainty. Br Med J (Clin Res Ed) 1987 May 2;294(6580):1111–1112. doi: 10.1136/bmj.294.6580.1111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brewin C. R., Bradley C. Patient preferences and randomised clinical trials. BMJ. 1989 Jul 29;299(6694):313–315. doi: 10.1136/bmj.299.6694.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Byar D. P. Problems with using observational databases to compare treatments. Stat Med. 1991 Apr;10(4):663–666. doi: 10.1002/sim.4780100417. [DOI] [PubMed] [Google Scholar]
- Chalmers I., Dickersin K., Chalmers T. C. Getting to grips with Archie Cochrane's agenda. BMJ. 1992 Oct 3;305(6857):786–788. doi: 10.1136/bmj.305.6857.786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chisholm G. D. Benign prostatic hyperplasia: the best treatment. BMJ. 1989 Jul 22;299(6693):215–216. doi: 10.1136/bmj.299.6693.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Concato J., Horwitz R. I., Feinstein A. R., Elmore J. G., Schiff S. F. Problems of comorbidity in mortality after prostatectomy. JAMA. 1992 Feb 26;267(8):1077–1082. [PubMed] [Google Scholar]
- Coulter A., McPherson K. Socioeconomic variations in the use of common surgical operations. Br Med J (Clin Res Ed) 1985 Jul 20;291(6489):183–187. doi: 10.1136/bmj.291.6489.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Doll H. A., Black N. A., McPherson K., Flood A. B., Williams G. B., Smith J. C. Mortality, morbidity and complications following transurethral resection of the prostate for benign prostatic hypertrophy. J Urol. 1992 Jun;147(6):1566–1573. doi: 10.1016/s0022-5347(17)37628-0. [DOI] [PubMed] [Google Scholar]
- Falck H. S. Social work in medical and health settings. Introduction. Soc Sci Med. 1990;31(1):1–4. doi: 10.1016/0277-9536(90)90002-a. [DOI] [PubMed] [Google Scholar]
- Feinstein A. R. Current problems and future challenges in randomized clinical trials. Circulation. 1984 Nov;70(5):767–774. doi: 10.1161/01.cir.70.5.767. [DOI] [PubMed] [Google Scholar]
- Fuller R., Roth H., Long S. Compliance with disulfiram treatment of alcoholism. J Chronic Dis. 1983;36(2):161–170. doi: 10.1016/0021-9681(83)90090-5. [DOI] [PubMed] [Google Scholar]
- Green S. B., Byar D. P. Using observational data from registries to compare treatments: the fallacy of omnimetrics. Stat Med. 1984 Oct-Dec;3(4):361–373. doi: 10.1002/sim.4780030413. [DOI] [PubMed] [Google Scholar]
- Henshaw R. C., Naji S. A., Russell I. T., Templeton A. A. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment. BMJ. 1993 Sep 18;307(6906):714–717. doi: 10.1136/bmj.307.6906.714. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Horwitz R. I., Viscoli C. M., Berkman L., Donaldson R. M., Horwitz S. M., Murray C. J., Ransohoff D. F., Sindelar J. Treatment adherence and risk of death after a myocardial infarction. Lancet. 1990 Sep 1;336(8714):542–545. doi: 10.1016/0140-6736(90)92095-y. [DOI] [PubMed] [Google Scholar]
- McPherson K., Wennberg J. E., Hovind O. B., Clifford P. Small-area variations in the use of common surgical procedures: an international comparison of New England, England, and Norway. N Engl J Med. 1982 Nov 18;307(21):1310–1314. doi: 10.1056/NEJM198211183072104. [DOI] [PubMed] [Google Scholar]
- Meyhoff H. H. Transurethral versus transvesical prostatectomy. Clinical, urodynamic, renographic and economic aspects. A randomized study. Scand J Urol Nephrol Suppl. 1987;102:1–26. [PubMed] [Google Scholar]
- Phillips D. P., Ruth T. E., Wagner L. M. Psychology and survival. Lancet. 1993 Nov 6;342(8880):1142–1145. doi: 10.1016/0140-6736(93)92124-c. [DOI] [PubMed] [Google Scholar]
- Pizzo P. A., Robichaud K. J., Edwards B. K., Schumaker C., Kramer B. S., Johnson A. Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo-controlled trial. J Pediatr. 1983 Jan;102(1):125–133. doi: 10.1016/s0022-3476(83)80310-2. [DOI] [PubMed] [Google Scholar]
- Resnick N. M., Yalla S. V., Laurino E. The pathophysiology of urinary incontinence among institutionalized elderly persons. N Engl J Med. 1989 Jan 5;320(1):1–7. doi: 10.1056/NEJM198901053200101. [DOI] [PubMed] [Google Scholar]
- Roos N. P., Roos L. L., Cohen M., Fisher E. S., McPherson K., Ramsey E., Andersen T. F., Wennberg J. E., Malenka D. J. Therapies for benign prostatic hyperplasia. JAMA. 1992 Sep 9;268(10):1269–1270. doi: 10.1001/jama.1992.03490100063027. [DOI] [PubMed] [Google Scholar]
- Sidney S., Quesenberry C. P., Jr, Sadler M. C., Cattolica E. V., Lydick E. G., Guess H. A. Reoperation and mortality after surgical treatment of benign prostatic hypertrophy in a large prepaid medical care program. Med Care. 1992 Feb;30(2):117–125. doi: 10.1097/00005650-199202000-00003. [DOI] [PubMed] [Google Scholar]
- WOLF S. Effects of suggestion and conditioning on the action of chemical agents in human subjects; the pharmacology of placebos. J Clin Invest. 1950 Jan;29(1):100–109. doi: 10.1172/JCI102225. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wennberg J. E., Barnes B. A., Zubkoff M. Professional uncertainty and the problem of supplier-induced demand. Soc Sci Med. 1982;16(7):811–824. doi: 10.1016/0277-9536(82)90234-9. [DOI] [PubMed] [Google Scholar]
- Wennberg J. E., McPherson K., Caper P. Will payment based on diagnosis-related groups control hospital costs? N Engl J Med. 1984 Aug 2;311(5):295–300. doi: 10.1056/NEJM198408023110505. [DOI] [PubMed] [Google Scholar]
- Wennberg J. E., Roos N., Sola L., Schori A., Jaffe R. Use of claims data systems to evaluate health care outcomes. Mortality and reoperation following prostatectomy. JAMA. 1987 Feb 20;257(7):933–936. [PubMed] [Google Scholar]